Efficacy and Safety of Near Infrared Light Therapy for Alzheimer's Disease

This study is investigating the use of near infrared light therapy as a potential treatment for Alzheimer's disease. Alzheimer's is a progressive brain disorder affecting memory and cognitive functions, making it challenging for those diagnosed and their families. The study aims to determine if this type of light therapy can improve symptoms or slow down the progression of the disease while also ensuring it is safe for patients. Finding effective treatments is crucial as current options are limited, and Alzheimer's significantly impacts quality of life. Participants in the study are divided into two groups: a treatment group receiving active near infrared light therapy and a control group receiving a sham or inactive treatment. The therapy is administered for 30 minutes daily, 5 to 6 days a week over a four-month period. Researchers evaluate the effectiveness and safety by conducting follow-up visits at intervals of 2 months and 4 months during treatment, and then again 2 months after the treatment ends. During these visits, participants undergo various assessments, including scale evaluations, blood tests, MRI scans, and EEG tests to monitor changes in their condition and any potential side effects.